PP
ELOX

Paloma Partners’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Paloma Partners’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-408
Closed -$120K – 2277
2019
Q4 		$120K Buy
+408
New +$82.2K ﹤0.01% 2038

Other funds holding ELOX

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Paloma Partners's ELOX Position: Q1 2020 in Review

Paloma Partners sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q1 2020, closing a stake of 408 shares — an estimated $120K sold.

Paloma Partners first reported a position in ELOX in Q4 2019 and held it in 1 quarter. The position peaked at $120K in Q4 2019. 43 funds tracked by Wall St. Rank hold ELOX as of Q1 2020.

  • Paloma Partners reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Paloma Partners sold 408 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q1 2020, an estimated $120K.
  • Paloma Partners first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
  • Paloma Partners's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $120K in Q4 2019.
  • 43 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q1 2020.

Based on Paloma Partners's 13F filing for Q1 2020, filed 15 May 2020.